tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Jasper Therapeutics (JSPR)
NASDAQ:JSPR
US Market
JSPR
Jasper Therapeutics
RESEARCH TOOLSreports

Jasper Therapeutics (JSPR) Stock News & Sentiment

Compare
1,058 Followers
Briquilimab’s Robust Efficacy and Favorable Safety in Urticaria Indicate Strong Upside for Jasper Therapeutics and Support a Buy Rating
Premium
Ratings
Briquilimab’s Robust Efficacy and Favorable Safety in Urticaria Indicate Strong Upside for Jasper Therapeutics and Support a Buy Rating
1d ago
JSPR
Jasper Therapeutics Reports Strong Briquilimab Data in Urticaria
Premium
Company Announcements
Jasper Therapeutics Reports Strong Briquilimab Data in Urticaria
2d ago
8K
JSPR
Maintaining Hold on Jasper: Awaiting Critical BEACON CSU Data to Resolve Clinical and Execution Uncertainty
Premium
Ratings
Maintaining Hold on Jasper: Awaiting Critical BEACON CSU Data to Resolve Clinical and Execution Uncertainty
2d ago
JSPR
Jasper Therapeutics announces leadership transition and briquilimab update
Premium
Company Announcements
Jasper Therapeutics announces leadership transition and briquilimab update
2d ago
8K
JSPR
3 Penny Stocks to Watch Now, 12/4/25
Premium
Market News
3 Penny Stocks to Watch Now, 12/4/25
1M ago
BQ
FTEL
Positive Outlook for Jasper Therapeutics: Buy Rating Reinforced by Briquilimab’s Promising Data and Strategic Plans
Premium
Ratings
Positive Outlook for Jasper Therapeutics: Buy Rating Reinforced by Briquilimab’s Promising Data and Strategic Plans
1M ago
JSPR
Jasper Therapeutics: Strategic Patient Selection and Consistent Drug Performance Justify Buy Rating
Premium
Ratings
Jasper Therapeutics: Strategic Patient Selection and Consistent Drug Performance Justify Buy Rating
1M ago
JSPR
More JSPR News >

JSPR News on the Web

Why Jasper Therapeutics, Inc.’s (JSPR) Stock Is Down 14.63%
AAII
Neutral
3 Penny Stocks to Watch Now, 12/4/25
TipRanks News
Neutral
Analysts Have Conflicting Sentiments on These Healthcare Companies: Jasper Therapeutics (JSPR) and Azitra Inc (AZTR)
TipRanks News
Neutral
Jasper Therapeutics Reports Positive Results For Briquilimab In Allergic Asthma Phase 1b Study
rttnews
Neutral
Jasper Therapeutics Webinar Sheds Light on Promising Briquilimab Studies in Asthma and Chronic Urticaria
Market Chameleon
Neutral
Jasper Therapeutics To Host Webinar To Present BEACON And ETESIAN Study Results
rttnews
Neutral
Why Jasper Therapeutics, Inc.’s (JSPR) Stock Is Down 5.43%
AAII
Neutral
Why Jasper Therapeutics, Inc.’s (JSPR) Stock Is Down 7.38%
AAII
Neutral

News Score - Last 7 Days

Neutral
JSPR
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JSPR’s Media Buzz Sentiment?
1 articles about JSPR were published this week. In an average week, 1 articles are published.
    What is JSPR’s weekly average amount of articles?
    In an average week, 1 articles about JSPR are published.
      What is JSPR’s News Sentiment?
      50% of articles about JSPR were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        GNPXGenprex
        ARDXArdelyx
        RIGLRigel
        MRKRMarker Therapeutics
        TILInstil Bio
        Showing the stocks with the most bullish news sentiment over the past week